Mihael H. Polymeropoulos
2013
In 2013, Mihael H. Polymeropoulos earned a total compensation of $2.5M as President and Chief Executive Officer at Vanda Pharmaceuticals.
Compensation breakdown
| Non-Equity Incentive Plan | $354,063 |
|---|---|
| Option Awards | $1,049,610 |
| Salary | $515,000 |
| Stock Awards | $579,500 |
| Other | $22,061 |
| Total | $2,520,234 |
Polymeropoulos received $1M in option awards, accounting for 42% of the total pay in 2013.
Polymeropoulos also received $354.1K in non-equity incentive plan, $515K in salary, $579.5K in stock awards and $22.1K in other compensation.
Rankings
In 2013, Mihael H. Polymeropoulos' compensation ranked 3,092nd out of 12,286 executives tracked by ExecPay. In other words, Polymeropoulos earned more than 74.8% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 3,092 out of 12,286 | 75th |
Division Manufacturing | 1,040 out of 4,612 | 78th |
Major group Chemicals And Allied Products | 273 out of 1,462 | 81st |
Industry group Drugs | 187 out of 1,156 | 84th |
Industry Pharmaceutical Preparations | 155 out of 890 | 83rd |
Source: SEC filing on April 28, 2016.
Polymeropoulos' colleagues
We found two more compensation records of executives who worked with Mihael H. Polymeropoulos at Vanda Pharmaceuticals in 2013.